Patient Health

orkambi for cystic fibrosis
Pediatric Health Pharmacological Sleep Disorders

FDA Approves ORKAMBI®, First Medicine to Treat the Underlying Cause of CF for Children Ages 2-5 Years with Most Common Form of the Disease

Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) has approved ORKAMBI® (lumacaftor/ivacaftor) to include use in children ages 2 through 5 years with cystic fibrosis (CF) who have two copies of the F508del-CFTR mutation, making it the first medicine approved to treat the underlying cause of CF […]

tired nurse ebb sleep
Patient Health

The Hidden Cost of Fatigue in Health Care

As hospitals try to reduce costs, sleep-deprived nurses pose significant and often overlooked costs to workplace efficiency and patient care Hospitals are losing more than an estimated $2.5 billion annually due to fatigue experienced by nurses nationwide. More than 1.6 million registered nurses[1] work in general medical or surgical hospitals […]